21 March, 2023

CHINA’S TOP 30 A-SHARES

Assessing the Accounting Risk

Gillem Tulloch

wisetech-global qinghai-salt haier-electronics gree-electric inner-mongolia-yili jiangsu-hengrui-pharma kweichow-moutai midea-group wuliangye-yibin shenzhen-inovance-technology hangzhou-hikvision-digital tongwei longi-green-energy-tech luxshare-precision-ind shenzhen-mindray-bio-medical-electronics wanhua-chemic contemporary-amperex-tech ganfeng-lithium sf-holding china-tourism-group-duty-free-corp aier-eye-hospital eve-energy muyuan-food sungrow-power boe-tech shanxi-xinghua wens-foods china-yangtze-power wuxi-apptec chongqing-changan-auto luzhou-laojiao

Insights

1 December, 2023

NEWSLETTER: EVERGRANDE (3333 HK)

Never profitable

Fredrik Oeqvist

Evergrande’s much delayed and recently published 2021 annual report makes clear that it significantly overstated revenue and earnings – most likely for many years. Contrary to what some people think, Evergrande was not so much a victim of tightened liquidity or a COVID-induced property market downturn; its problems were far more fundamental – there were never any profits....

18 August, 2020

NEWSLETTER: COMING HOME?

Watch out for the privatisation “squeeze out”

The proposed Holding Foreign Companies Accountable Act could force hundreds of Chinese companies listed on US exchanges to delist over the next few years. For many large companies, seeking a secondary listing in Hong Kong or the mainland is a sensible insurance policy. However, investors should be wary of companies which decide to privatise and then relist. Our analysis of...